Show simple item record

dc.contributor.authorHatemi, Gülen
dc.contributor.authorYAZICI, Yılmaz
dc.contributor.authorOZGULER, Yeşim
dc.contributor.authorYAZICI, H
dc.date.accessioned2021-03-02T20:53:24Z
dc.date.available2021-03-02T20:53:24Z
dc.identifier.citationYAZICI H., OZGULER Y., Hatemi G., YAZICI Y., "Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.", Arthritis & rheumatology (Hoboken, N.J.), cilt.68, ss.1315-6, 2016
dc.identifier.issn2326-5191
dc.identifier.othervv_1032021
dc.identifier.otherav_0432909a-a233-41d6-8dd5-e89d428ab212
dc.identifier.urihttp://hdl.handle.net/20.500.12627/8762
dc.identifier.urihttps://doi.org/10.1002/art.39633
dc.language.isoeng
dc.titleRecommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.
dc.typeMakale
dc.relation.journalArthritis & rheumatology (Hoboken, N.J.)
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume68
dc.identifier.startpage1315
dc.identifier.endpage6
dc.contributor.firstauthorID159770


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record